Navigation Links
Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
Date:5/20/2009

Free Access Given to Support the Global R&D and Healthcare Community

PHILADELPHIA and LONDON, May 20 /PRNewswire/ -- In support of the efforts of the global healthcare community working to prevent and address outbreaks such as the current Influenza A (H1N1) flu outbreak, the Healthcare and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the free availability of its Disease Briefing on Influenza taken directly from the wealth of information and knowledge in Prous Science Integrity(R).

The daily briefing can be downloaded from http://science.thomsonreuters.com/pharma/h1n1/, and provides information on Influenza A (H1N1) including:

  • Development pipeline for related drugs and vaccines
  • Number of laboratory confirmed cases
  • International response to the pandemic
  • Other critical information resources

The information provided in this disease briefing uses a drug R&D approach designed for life sciences researchers, versus the medical or epidemiological approaches found elsewhere, and focuses on drugs and vaccinations that are currently in the development pipeline or on the market.

Disease Briefings are dynamic executive summaries of the current status and future trends in drug therapy for a specific disease or disorder. They provide key facts on the disease -- such as risk factors, prevalence and incidence, morbidity and mortality figures, cost -- along with a structured, scientific approach to the drug R&D-related aspects of diagnosis, prevention and treatment.

"Disease Briefings utilize a scientific viewpoint to describing vaccines and drug therapies that are currently under development. This approach accelerates the understanding of the disease and hypotheses to direct new research," said Jon Brett-Harris, EVP Life Sciences, Thomson Reuters. "It is our hope that making this data freely available will aid researchers and investigators who are responding to this challenge."

The Prous Science Integrity drug discovery and development portal includes 107 Disease Briefings on diseases and disorders ranging from Acne to Cancer to West Nile Fever. The Disease Briefings are fully integrated into Prous Science Integrity's suite of scientific information and tools covering the biology, chemistry and pharmacology of drug discovery and development. In Prous Science Integrity, users can link from a Disease Briefing to display the chemical structures and synthesis of the compounds in development to information on the biology of the corresponding drug targets -- along with results from preclinical and clinical studies on these compounds.

About Prous Science Integrity

Prous Science Integrity is a unique knowledge solution designed to empower discovery activities right where this is most needed -- at the bench. The Prous Science Integrity portal integrates biological, chemical and pharmacological data on more than 300,000 compounds with demonstrated biological activity. For more information, go to http://go.thomsonreuters.com/integrity.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Examines Highly Cited Research in Bioterrorism
2. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
3. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
4. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
5. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
6. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
7. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
8. Thomson Reuters Launches New Biomarkers Solution
9. Thomson Scientific Begins Expansion of Web of Science
10. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
11. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... 23, 2017 , ... Cambridge Semantics , the leading provider of Big ... World Conference and Expo in Boston May 23-25 with a featured speaker and ... Smart Data Lake is also a finalist for the Best of Show award. , ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... ... announced today that it is exhibiting in booth B2 at the Association for ... Pittsburgh, May 22-25. , In addition to demonstrating its Cancer Diagnostic Cockpit ...
(Date:5/19/2017)... , ... May 19, 2017 , ... ... Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who are ... and Delaware, are encouraged to submit proposals. QED, now in its tenth round, ...
(Date:5/18/2017)... VIRGINIA (PRWEB) , ... May 17, 2017 , ... NDA ... business executive and former CEO of Eurofins Advantar Laboratories and President of Pharmaceutical Development ... addition to his position at Eurofins and Cardinal Health, he was former Chief Operating ...
Breaking Biology Technology:
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
Breaking Biology News(10 mins):